Based on recent litigation, Sanofi-Aventis only started out to warn Oughout. S. patients of the risk of long term alopecia after being mandated to do so by the fda in December 2015, even though patients outside of the Oughout. S. was warned about long term hair loss as early as 2005.
Because of this because U. S. physicians and patients were unaware of Taxotere’s risk of everlasting alopecia, the option of using an alternative chemotherapy drug that is as effective as Taxotere, but without its long term aspect effects, was rarely used. To hire best taxotere hair loss lawyers you can also browse online.
During chemotherapy, hair thinning is a well-known indication, but is likely to grow again within 3-6 weeks of preventing treatment. Alopecia will come in numerous forms, including:
- Non-existent hair regrowth under arms or about genitals
- Insufficient eyelashes
- Insufficient eyebrows
Total hair thinning on both head and body
Absolute hair thinning on the head and is a particular form of alopecia called alopecia universalis, which is the most typical hair thinning condition reported with Taxotere use.
While chemotherapy drugs are anticipated to eliminate or decrease the development of cancer skin cells without the risk of long lasting side results, recent lawsuits from women in the united states allege the particular one of the very most trusted chemotherapy drugs in the U.S. is triggering long term hair thinning, or alopecia, in unsuspecting malignancy patients.